基于甘油三酯-葡萄糖乘积指数观察脂必泰胶囊治疗痰瘀互结型2型糖尿病合并代谢综合征临床疗效OA
Clinical Efficacy of Zhibitai Capsule(脂必泰胶囊)in Treatment of Type 2 Diabetes Mellitus Complicated with Metabolic Syndrome of Accumulation of Phlegm and Blood Stasis Syndrome Based on Triglyceride-Glucose Index
目的 通过观察甘油三酯-葡萄糖(Triglyceride-glucose,TyG)乘积指数等指标评价脂必泰胶囊治疗2型糖尿病(Type 2 diabetes mellitus,T2DM)合并代谢综合征(Metabolic syndrome,MS)的临床疗效.方法 将80例痰瘀互结型T2DM合并MS患者按照随机数字表法随机分为观察组和对照组,每组各40例.两组均给予生活方式干预,根据患者具体病情给予降糖、降压、减重等基础治疗,对照组在基础治疗上加用阿托伐他汀钙片调脂,睡前口服1片,疗程共8周;观察组在基础治疗上加用脂必泰胶囊调脂,1粒/次,2次/d,疗程共8周.观察两组患者治疗前后中医证候学积分、体质指数(Body mass index,BMI)、腰围、收缩压(Systolic blood pressure,SBP)、舒张压(Diastolic blood pressure,DBP)、空腹血糖(Fasting blood glucose,FBG)、糖耐量试验 2 h 后血糖(Blood glucose after 2 hours of oral glucose tolerance test,2HBG)、糖化血红蛋白(Glycosylated hemoglobin A1c,HBA1c)、空腹胰岛素(Fasting plasma insulin,INS)、糖耐量 2 h 后胰岛素(Insulin after 2 hours of oral glucose tolerance test,INS-2H)、总胆固醇(Total cholesterol,TC)、甘油三酯(Triglyceride,TG)、低密度脂蛋白胆固醇(Low density lipoprotein cholesterol,LDL-C)、高密度脂蛋白胆固醇(High density lipoprotein cholesterol,HDL-C)、TyG 指数、稳态模型胰岛素抵抗指数(Homeostasis model assessment of insulin resistance,HOMA-IR)的变化及中医证候疗效.结果 治疗后,观察组中医证候疗效总有效率为82.5%(33/40),高于对照组的57.5%(23/40)(P<0.05);两组治疗后中医证候学积分较治疗前均降低(P<0.01),治疗后,观察组中医证候学积分较对照组降低(P<0.01);两组治疗后 FBG、2HBG、HBA1c、SBP、DBP、TC、TG、TyG 指数、HOMA-IR 指数较治疗前均降低(P<0.01),HDL-C较治疗前升高(P<0.01),BMI、腰围、INS、INS-2H较治疗前差异无明显统计学意义(P>0.05);治疗后,观察组 FBG、2HBG、HBA1 c、TyG 指数、HOMA-IR 指数均较对照组降低(P<0.05 或 P<0.01),BMI、腰围、INS、INS-2H、SBP、DBP、TC、TG、LDL-C、HDL-C较对照组差异无明显统计学意义(P>0.05).结论 脂必泰胶囊能减少T2DM合并MS中医证候学积分,降低患者血脂、血糖、TyG指数及HOMA-IR指数,减轻IR,从而改善患者临床症状,提高中医证候疗效有效率.
Objective To evaluate the effect of Zhibitai Capsule(脂必泰胶囊)on the patients with type 2 diabetes mellitus(T2DM)complicated with metabolic syndrome(MS)of accumulation of phlegm and blood stasis syndrome by observing triglycer-ide-glucose(TyG)index and other indicators.Methods According to the random number table method,80 cases of T2DM com-plicated with MS of accumulation of phlegm and blood stasis syndrome were randomly divided into treatment group and control group,with 40 cases in each group.Both groups were given lifestyle intervention and basic treatment such as reducing blood glu-cose,lowering blood pressure and losing weight according to the specific condition of the patients.The control group was given the basic treatment and atorvastatin calcium tablet for lipid regulation,one tablet orally at bedtime for a total of 8 weeks.The treat-ment group was supplemented with Zhibitai Capsule,twice a day,1 capsule for each time,and the course of treatment was 8 weeks.The changes in TCM syndrome scores,body mass index(BMI),waist circumference,systolic blood pressure(SBP),dias-tolic blood pressure(DBP),fasting blood glucose(FBG),blood glucose after 2 hours of oral glucose tolerance test(2 h BG),gly-cosylated hemoglobin(HBA1c),fasting insulin(INS),insulin after 2 hours of oral glucose tolerance test(INS-2 h),total choles-terol(TC),triglycerides(TG),low density dilipoprotein cholesterol(LDL-C),high-density lipoprotein cholesterol(HDL-C),TyG index,homeostasis model IR index(HOMA-IR)of the two groups were observed before and after the treatment.Results The total effective rate of the treatment group was 82.5%(33/40)after treatment,which was higher than 57.5%(23/40)of the control group(P<0.05).After treatment,the TCM syndrome scores of the two groups were lower than those before treatment(P<0.01).The TCM syndrome scores of the treatment group after treatment were lower than those of the control group(P<0.01).After treatment,the levels of FBG,2 h BG,HBA1 c,SBP,DBP,TC,TG,LDL-C,TyG index and HOMA-IR of both groups were lower than those before.HDL-C was higher than that before treatment(P<0.01).The values of BMI,waist circumference,INS and INS-2 h had no significant difference(P>0.05).The levels of FBG,2 h BG,HBA1c,TyG index and HOMA-IR of the treatment group after treatment were lower than those of the control group(P<0.05 or P<0.01).There were no significant differences in BMI,waist circumference,INS,INS-2 h,SBP,DBP,TC,TG,LDL-C or HDL-C compared with those of the control group(P>0.05).Conclusion Zhibitai Capsule can reduce the TCM syndrome scores of T2DM complicated with MS patients,reduce their blood glucose,blood lipids,TyG,HOMA-IR and IR,thereby improving the clinical symptoms and the clinical efficacy of TCM syndromes.
谢勤;倪英群;江昊原;王维维
安徽中医药大学附属铜陵中医医院,安徽铜陵 244000安徽中医药大学第一附属医院,安徽 合肥 230012安徽中医药大学,安徽 合肥 230038安徽中医药大学,安徽 合肥 230038
医药卫生
脂必泰胶囊MST2DMTyG指数HOMA-IR指数
Zhibitai Capsule(脂必泰胶囊)MST2DMtriglyceride-glucose(TyG)indexHOMA-IR
《中华中医药学刊》 2026 (5)
49-53,5
国家自然科学基金项目(82274468)安徽省名中医陈晓雯工作室项目(中医药发展秘[2018]11号)安徽省中医重点专科发展专项(卫办秘[2017]536)安徽中医药大学重点科研项目(2024LC032)
评论